Aspirin May Lower Risk for Bile Duct CancerAspirin May Lower Risk for Bile Duct Cancer
Observational data show that low-dose aspirin users have reduced risk for bile duct cancer in all three subtypes of cholangiocarcinoma. Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
More News: Aspirin | Bile | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Gastroenterology | Hematology